GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a truly shift in how we handle type 2 diabetes . These new therapies help stimulating the body’s natural GLP-1 hormone , which promotes glucose https://reta083449.blog-a-story.com/profile